Guerbet launches a new multi-patient solution, with no compromise on efficiency and patient safety
Presented for the first time at the Radiological Society of North America meeting (RSNA, Chicago, November 25–30, 2018), this solution broadens Guerbet’s multi-patient range.
Villepinte, November 23, 2018 (8:00 CET) - Guerbet, a global specialist in contrast agents and solutions for medical imaging, announced today that the OptiVantage® multi-use injector is now CE-marked. This injector is designed for injecting contrast agents used in X-ray (CT scan) medical examinations.
This new solution includes the tried-and-tested OptiVantage® syringe-based injector, a complete range of associated syringes and disposables (manyFill® day set and secufill® patient line), services and support systems (OptiProtect™).
OptiVantage® multi-use will initially be marketed in EMEA from January 2019, then progressively in other regions of the world (Asia and Latin America).
Existing OptiVantage® customers may benefit from an upgrade to easily implement the new multi-use feature.
The market targeted by OptiVantage® multi-use represents over half of all CT procedures worldwide.
Press release
About Vectorio®
Vectorio® is a medical device of Class Is (CE 0459) intended to be used by healthcare professionals only. Manufacturer: Medex, a Guerbet Group company. Intended use: Lipiodol® Resistant Mixing and Injection System for conventional Trans-Arterial Chemo-Embolization (cTACE). For complete information please refer to Instruction For Use.
About Lipiodol® Ultra-Fluid
Lipiodol® Ultra-Fluid (ethyl esters of iodized fatty acids of poppyseed oil) was initially developed for diagnostic radiology in indications including liver lesion diagnosis, lymphography and hysterosalpingography, and then used in interventional radiology for conventional trans-arterial chemo-embolization (cTACE) procedures of multinodular hepatocellular carcinoma, where Lipiodol® Ultra-Fluid was used as a procedure visualizer (contrast agent), a drug vehicle (drug carrier), and an embolic. The approved indications for Lipiodol® Ultra-Fluid may vary according to countries. For complete information please refer to local Summary of Product Characteristics.